NVAX. % Owned by Institutions 87.04 segun Morningstar.
si, nuestro "querido" sector esta, como dicen lo usanos, "lagging" ....
Novavax Receives an Outperform from Wedbush
In a report issued on February 29, Heather Behanna from Wedbush reiterated an Outperform rating on Novava.
Behanna noted, “Novavax reports FY15 results with EPS of ($0.29) for 4Q15, greater than our estimates and consensus due to a large increase in R&D spend to get two RSV studies up and running. We anticipate R&D expense will decline after the RSV season in 2Q and 3Q16.”
este comentario lo saco de la ronda de preguntas de la conferencia
NVAX
Gilead Sciences (GILD 89.69 +2.44 2.80%) announced that the FDA has approved its defsey (emtricitabine 200mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg)(R/F/TAF) for the treatment of HIV-1 infection in certain patients. This is the company's second TAF-based regimen cleared in the U.S.
ADXS
Admisión post plazo en simposio por datos importantes
http://finance.yahoo.com/news/advaxis-study-head-neck-cancer-120500534.html
Primeros minutos de calma chicha.
IBB, velas 1h, que impetu, no? a ver cuando para a respirar
Me lo empiezo a creer
NVAX
